UNSPSC 51101939: Acediasulfone

This classification denotes an antibiotic with the chemical formula C14H14N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30YP2YHH8W, chemically known as n-[4-[(4-aminophenyl)sulfonyl]phenyl]glycine, but which is more commonly know as acediasulfone. European Medicines Agency schedules Acediasulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00242MIG.

The term ACEDIASULFONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) As of Q4 2014, ACEDIASULFONE remains the US FDA Preferred Term for this commodity. Acediasulfone bears US NLM identifiers UMLS ID C1958507 and NCI Concept Code C77129. SMILES: C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)NCC(=O)O.

UNSPSC 51101939 Acediasulfone is a Commodity code that state and local governments use to classify pharmaceutical products and medical supplies, though recent solicitations tagged under this code reveal significant misalignment between the nominal classification and the work actually being procured. State and local health agencies, fire departments, and cooperative purchasing alliances are acquiring naloxone, pharmaceutical products, and first-aid supplies through open competitive bidding. The issuing bodies include county health departments (Seminole County, Florida), municipal fire-rescue divisions (Tampa Fire Department), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities). Solicitations are structured as formal ITBs with firm response deadlines, IFBs with sealed-bid submission requirements, and RFPs with detailed product and pricing specifications. Contracts typically include standard compliance requirements such as workers' compensation and commercial general liability insurance, drug-free workplace certification, and E-Verify employment authorization verification; procurement documents reference FDA compliance, Drug Supply Chain Security Act (DSCSA) certification, current Good Manufacturing Practices (cGMP), and federal environmental regulations when FEMA funding is involved. Award periods generally span one to two years with optional renewal terms.

Geographic activity centers on Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving a broader multistate footprint including Oregon. Representative recent solicitations include Seminole County's IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's ITB 26P00145 (due March 13, 2026) for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a Small Local Business Enterprise set-aside and 5 percent bid discount; the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers with July 1, 2026 contract effective date; and the Texas HHS Commission RFI HHS0017013 (due April 3, 2026) for direct-to-manufacturer prescription program capabilities as market intelligence for future formal solicitation. The code shows active but fragmented procurement activity across health departments and municipal agencies; pursuit merit depends on production and distribution capacity for pharmaceutical or medical-supply products meeting FDA, DSCSA, and cGMP requirements and ability to support quarterly or regular deliveries to public health and emergency-response facilities.